Hyaluronate activates tyrosine phosphorylation of cellular proteins including focal adhesion kinase via CD44 in human glioma cells

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 561-564

  Ohta, Seiji ^a   Yoshida, Jun ^a   Iwata, Hiroyuki ^a   Hamaguchi, Michinari ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44; focal adhesion kinase; human glioma cells; hyaluronate; tyrosine phosphorylation

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; PROTEIN KINASE; TYROSINE;

ARTICLE; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

EID: 0030901157     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.3.561     Document Type: Article

References (32)

1. Yoshida J, Kajita Y, Wakabayashi T and Sugita K: Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumor resection and postoperative adjuvant therapy with interferon, ACNU and radiation. Acta Neurochir 127: 55-59, 1994.
2. Stamenkovic I, Amiot M, Pesando JM and Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057-1062, 1989.
3. Goldstein LA, Zho DFH, Picker LJ, Minty CN, Bargatze RF, Ding JF and Butcher EC: A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage protcoglycan core and link proteins. Cell 56: 1063-1072, 1989.
4. Asher R and Bignami A: Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203: 80-90, 1992.
5. Couldwell WT, de Tribolet N, Antel JP, Gauthier T and Kuppncr MC: Adhesion molecules and malignant gliomas: implications for tumorigenesis. J Neurosurg 76: 782-791, 1992.
6. Kuppner MC, Van ME, Gauthier T, Hamou M-F and de Tribolet N: Differential expression of the CD44 molecule in human brain tumors. Int J Cancer 50: 572-577, 1992.
7. Okada H, Yoshida J, Seo H, Wakabayashi T, Sugita K and Hagiwara M: Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes overexpressed CD44 in glioma cells. Cancer Immunol Immunother 39: 313-317, 1994.
8. Sy MS, Guo Y-J and Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859-866, 1991.
9. Bartolazzi A, Peach R, Aruffo A and Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66, 1994.
10. Merzak A, Koochcckpour S and Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54: 3988-3992, 1994.
11. Aruffo A, Stamenkovic I, Melnick M, Underhill CB and Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313, 1990.
12. Iwata H, Ito T, Mutoh T, Ishiguro Y, Xiao H and Hamaguchi M: Abundant but inactive gp140proto-trk is expressed in neuroblastomas of patients with good prognosis. Jpn J Cancer Res 85: 32-39, 1994.
13. Hamaguchi M, Grandori C and Hanafusa H: Phosphorylation of cellular proteins in Rous sarcoma virus-infected cells: analysis by use of anti-phosphotyrosine antibodies. Mol Cell Biol 8: 3035-3042, 1988.
14. Takeshima E, Hamaguchi M, Watanabe T, Akiyama S, Kataoka M, Ohnishi Y, Xiao H, Nagai Y and Takagi H: Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells. Jpn J Cancer Res 82: 1428-1435, 1991.
15. Hamaguchi M and Hanafusa H: Association of p60src with Triton X-100-resistant cellular structure correlates with morphological transformation. Proc Natl Acad Sci USA 84: 2312-2316, 1987.
16. v-src causes tyrosine phosphorylation and inactivasion of the N-cadherin-catenin cell adhesion system. EMBOJ 12: 307-314, 1993.
17. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM and Turley EA: Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 117: 1343-1350, 1991.
18. Ilic D, Furuta Y, Kanazawa A, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T and Aizawa S: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544, 1995.
19. Hanks SK, Calalb MB, Harper MC and Patel SK: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 89: 8487-8491, 1992.
20. Chen Q, Kinch MS, Lin TH, Burridge K and Juliano RL: Integrin-mediated cell adhesion activates mitogen-activated protein kinase. J Biol Chem 269: 26602-26605, 1994.
21. Clark EA and Brugge JS: Integrins and signal transduction pathways: the road taken. Science 268: 233-239, 1995.
22. Schlaepfer DD, Hanks SK, Hunter T and van der Geer P: Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372: 786-791, 1992.
23. Kornberg L, Earp HS, Parson JT, Schaller M and Juliano RL: Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 267: 23439-23442, 1992.
24. Guan J-L and Shalloway D: Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358: 690-692, 1992.
25. Pelech SL and Sanghera JS: MAP kinases: Charting the regulatory pathways. Science 257: 1355-1356, 1993.
26. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993.
27. Nishida E and Gotoh Y: The MAP kinase cascade is essential for diverse signal transduction pathways. TIBS 18: 128-131, 1993.
28. Cobb MH and Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
29. Gallego C, Gupta SK, Heasley LE, Qian N-X and Johnson GL: Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH3T3 and Ratla cells. Proc Natl Acad Sci USA 89: 7355-7359, 1992.
30. Okazaki K and Sagata N: MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. Oncogene 10: 1149-1157, 1995.
31. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF and Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
32. Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.